Caitong International Asset Management’s vTv Therapeutics VTVT Stock Holding History

Caitong International Asset Management’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75	Buy	+2	New	+$69	﹤0.01%	2259

Other funds holding VTVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Caitong International Asset Management's VTVT Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 2 shares worth $75. The stake represents ﹤0.01% of the portfolio and ranks #2259 among its holdings.

12 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

Caitong International Asset Management held 2 shares of vTv Therapeutics worth $75 as of Q2 2026.
vTv Therapeutics was a new Caitong International Asset Management position in Q2 2026.
vTv Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2259 holding.
12 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.